Your browser doesn't support javascript.
loading
Treatment with Paracetamol Can Interfere with the Intradialytic Optical Estimation in Spent Dialysate of Uric Acid but Not of Indoxyl Sulfate.
Adoberg, Annika; Paats, Joosep; Arund, Jürgen; Dhondt, Annemieke; Fridolin, Ivo; Glorieux, Griet; Holmar, Jana; Lauri, Kai; Leis, Liisi; Luman, Merike; Pilt, Kristjan; Uhlin, Fredrik; Tanner, Risto.
Afiliación
  • Adoberg A; Centre of Nephrology, North Estonia Medical Centre, 13419 Tallinn, Estonia.
  • Paats J; Department of Health Technologies, Tallinn University of Technology, 19086 Tallinn, Estonia.
  • Arund J; Department of Health Technologies, Tallinn University of Technology, 19086 Tallinn, Estonia.
  • Dhondt A; Nephrology Division, Ghent University Hospital, 9000 Ghent, Belgium.
  • Fridolin I; Department of Health Technologies, Tallinn University of Technology, 19086 Tallinn, Estonia.
  • Glorieux G; Nephrology Division, Ghent University Hospital, 9000 Ghent, Belgium.
  • Holmar J; Department of Health Technologies, Tallinn University of Technology, 19086 Tallinn, Estonia.
  • Lauri K; Synlab Eesti OÜ, 10138 Tallinn, Estonia.
  • Leis L; Centre of Nephrology, North Estonia Medical Centre, 13419 Tallinn, Estonia.
  • Luman M; Centre of Nephrology, North Estonia Medical Centre, 13419 Tallinn, Estonia.
  • Pilt K; Department of Health Technologies, Tallinn University of Technology, 19086 Tallinn, Estonia.
  • Uhlin F; Department of Health Technologies, Tallinn University of Technology, 19086 Tallinn, Estonia.
  • Tanner R; Department of Health Technologies, Tallinn University of Technology, 19086 Tallinn, Estonia.
Toxins (Basel) ; 14(9)2022 09 01.
Article en En | MEDLINE | ID: mdl-36136548
ABSTRACT
Optical online methods are used to monitor the haemodialysis treatment efficiency of end stage kidney disease (ESKD) patients. The aim of this study was to analyse the effect of the administration of UV-absorbing drugs, such as paracetamol (Par), on the accuracy of optical monitoring the removal of uremic toxins uric acid (UA) and indoxyl sulfate (IS) during standard haemodialysis (HD) and haemodiafiltration (HDF) treatments. Nine patients received Par in daily dosages 1−4 g for 30 sessions. For 137 sessions, in 36 patients the total daily dosage of UV-absorbing drugs was less than 500 mg, and for 6 sessions 3 patients received additional UV-absorbing drugs. Par administration slightly affected the accuracy of optically assessed removal of UA expressed as bias between optically and laboratory-assessed reduction ratios (RR) during HD but not HDF employing UV absorbance of spent dialysate (p < 0.05) at 295 nm wavelength with the strongest correlation between the concentration of UA and absorbance. Corresponding removal of IS based on fluorescence at Ex280/Em400 nm during HD and HDF was not affected. Administration of UV-absorbing drugs may in some settings influence the accuracy of optical assessments in spent dialysate of the removal of uremic solutes during haemodialysis treatment of ESKD patients.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hemodiafiltración / Fallo Renal Crónico Límite: Humans Idioma: En Revista: Toxins (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estonia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hemodiafiltración / Fallo Renal Crónico Límite: Humans Idioma: En Revista: Toxins (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estonia